TY - JOUR
T1 - The multi-faceted nature of HLA class I dimer molecules
AU - Campbell, Elaine C
AU - Antoniou, Antony N
AU - Powis, Simon J
N1 - © 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.
PY - 2012/8
Y1 - 2012/8
N2 - The canonical role of major histocompatibility complex class I (MHCI) molecules in antigen presentation involves the recognition of a short peptide of intracellular origin, bound to the upper surface of the class I molecule, by CD8(+) T lymphocytes. Assembly and loading of the MHCI is a highly regulated, chaperone-mediated process and only when the fully folded MHCI molecule is correctly loaded with peptide is it released from the endoplasmic reticulum for trafficking to the cell surface. Current models of the interactions of MHCI molecules with their cognate receptors visualize them functioning as monomeric entities. However, in recent years, new data have revealed MHCI molecules with the ability to form disulphide-linked dimeric structures, with several distinct dimer entities being elucidated. We describe here three types of MHCI dimers; HLA-B27 dimers formed predominantly through the possession of an unpaired cysteine within the peptide-binding groove; HLA-G dimers, which form through a cysteine on its external surface; and a novel population we term redox-induced dimers, which can form between cysteine residues in the cytoplasmic tail domains. The characteristics of these dimeric MHCI molecules and their role in both normal immune responses and in disease pathogenesis are reviewed in this article.
AB - The canonical role of major histocompatibility complex class I (MHCI) molecules in antigen presentation involves the recognition of a short peptide of intracellular origin, bound to the upper surface of the class I molecule, by CD8(+) T lymphocytes. Assembly and loading of the MHCI is a highly regulated, chaperone-mediated process and only when the fully folded MHCI molecule is correctly loaded with peptide is it released from the endoplasmic reticulum for trafficking to the cell surface. Current models of the interactions of MHCI molecules with their cognate receptors visualize them functioning as monomeric entities. However, in recent years, new data have revealed MHCI molecules with the ability to form disulphide-linked dimeric structures, with several distinct dimer entities being elucidated. We describe here three types of MHCI dimers; HLA-B27 dimers formed predominantly through the possession of an unpaired cysteine within the peptide-binding groove; HLA-G dimers, which form through a cysteine on its external surface; and a novel population we term redox-induced dimers, which can form between cysteine residues in the cytoplasmic tail domains. The characteristics of these dimeric MHCI molecules and their role in both normal immune responses and in disease pathogenesis are reviewed in this article.
KW - Antigen Presentation
KW - CD8-Positive T-Lymphocytes/immunology
KW - Genes, MHC Class I
KW - HLA-B27 Antigen/chemistry
KW - HLA-G Antigens/chemistry
KW - Histocompatibility Antigens Class I/chemistry
KW - Humans
KW - Protein Multimerization
U2 - 10.1111/j.1365-2567.2012.03593.x
DO - 10.1111/j.1365-2567.2012.03593.x
M3 - Review article
C2 - 22533699
SN - 0019-2805
VL - 136
SP - 380
EP - 384
JO - Immunology
JF - Immunology
IS - 4
ER -